Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe

Guardado en:
Detalles Bibliográficos
Publicado en:Kidney International vol. 71, no. 1 (Jan 2007), p. 53
Autor principal: P C W van Dijk
Otros Autores: Zwinderman, A H, Dekker, F W, Schön, S, Stel, V S, Finne, P, Jager, K J
Publicado:
Elsevier Limited
Materias:
Acceso en línea:Citation/Abstract
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 210114860
003 UK-CbPIL
022 |a 0085-2538 
022 |a 1523-1755 
024 7 |a 10.1038/sj.ki.5002008  |2 doi 
035 |a 210114860 
045 2 |b d20070101  |b d20070131 
084 |a 17091125 
084 |a 70303  |2 nlm 
100 1 |a P C W van Dijk 
245 1 |a Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe 
260 |b Elsevier Limited  |c Jan 2007 
513 |a Journal Article 
520 3 |a   In Europe there is considerable variation in mortality on renal replacement therapy (RRT). The causes of this variation are still poorly understood. We hypothesized that differences in mortality in the general population contribute to differences in mortality on RRT. To evaluate this relationship, we studied general population statistics obtained from Eurostat and the individual data of 67,692 patients on RRT from 15 national and regional renal registries. These 15 registries were divided into two geographical regions: North and South Europe. Cox regression was used to assess the relative risk of death (RR) for each region with adjustment for age, gender, diabetes, and additionally general population mortality. In patients on RRT the age, gender and diabetes adjusted RR of death was 0.65 (95% CI (0.64-0.66)) for South compared to North, while in the general population the age and gender standardized RR of death was 0.91. After adjustment for general population mortality in addition to age, gender, and diabetes, the RR of death for patients on RRT in the South changed from 0.65 to 0.74 (95% CI (0.72-0.75)), which indicates that general population mortality accounted for 26% of the region-related mortality difference on RRT. In conclusion, within Europe there exist considerable international differences in the mortality of patients on RRT. Twenty-six percent of the European north-south mortality difference in RRT could be attributed to differences in general population mortality. Our data support the hypothesis that general population mortality is an important factor to take into account when making RRT mortality comparisons. 
650 2 2 |a Aged 
650 2 2 |a Epidemiologic Factors 
650 2 2 |a Epidemiologic Methods 
650 2 2 |a Europe  |x epidemiology 
650 2 2 |a Female 
650 2 2 |a Humans 
650 1 2 |a Kidney Failure, Chronic  |x mortality 
650 1 2 |a Kidney Failure, Chronic  |x therapy 
650 2 2 |a Male 
650 2 2 |a Middle Aged 
650 2 2 |a Proportional Hazards Models 
650 2 2 |a Registries 
650 1 2 |a Renal Replacement Therapy  |x mortality 
650 2 2 |a Risk Factors 
650 2 2 |a Selection Bias 
700 1 |a Zwinderman, A H 
700 1 |a Dekker, F W 
700 1 |a Schön, S 
700 1 |a Stel, V S 
700 1 |a Finne, P 
700 1 |a Jager, K J 
773 0 |t Kidney International  |g vol. 71, no. 1 (Jan 2007), p. 53 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/210114860/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/210114860/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch